Cargando…

An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar

INTRODUCTION: Breast cancer has been the most common cancer type that affects women worldwide and subsequent treatment is often associated with considerable psychological and quality of life (QoL). AIM: This study aimed to assess psychometric properties of the Arabic version of the European Organiza...

Descripción completa

Detalles Bibliográficos
Autores principales: Bener, Abdulbari, Alsulaiman, Reem, Doodson, Lisa, El Ayoubi, Hanadi R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848406/
https://www.ncbi.nlm.nih.gov/pubmed/29564271
http://dx.doi.org/10.4103/jfmpc.jfmpc_17_17
_version_ 1783305869206749184
author Bener, Abdulbari
Alsulaiman, Reem
Doodson, Lisa
El Ayoubi, Hanadi R.
author_facet Bener, Abdulbari
Alsulaiman, Reem
Doodson, Lisa
El Ayoubi, Hanadi R.
author_sort Bener, Abdulbari
collection PubMed
description INTRODUCTION: Breast cancer has been the most common cancer type that affects women worldwide and subsequent treatment is often associated with considerable psychological and quality of life (QoL). AIM: This study aimed to assess psychometric properties of the Arabic version of the European Organization for Research and Treatment of Cancer (EORTC) general QoL questionnaire (QLQ-C30) for breast cancer patients in Qatar. MATERIALS AND METHODS: This is a cross-sectional hospital-based study conducted on 678 breast cancer patients using Arabic version of the EORTC QLQ-C30 tool. RESULTS: The mean age of women was 47.7 ± 10.2 years and 33.4% of women had consanguineous parents. Six subscales out of the nine met the standards of reliability with coefficients ranging from 0.55 to 0.89. The mean score of all functioning scales was high >55. Advanced breast cancer stages of III–IV had higher symptomatic scores significantly than those in early stages for the physical function, cognitive, fatigue, insomnia, appetite loss, constipation, and financial difficulties. Correlation coefficients between each item ranged from –0.113 to 0.960, and item 21 (tense) and item 23 (irritable) had strongest negative correlations with their corresponding emotional functioning subscale, whereas items 29 (physical condition) and 30 (overall QoL) had the strongest positive correlation with Global Health/QoL subscale. Item 6 (limited work) showed a higher correlation with fatigue (r = 0.749). Likewise, item 19 (pain interfered with daily activities) of the pain subscale had higher correlations with physical functioning, role functioning, and fatigue subscales. CONCLUSION: Qatari Arabic version of the EORTC QLQ-C30 showed acceptable psychometric properties, which is a reliable and valid instrument, that can be used by oncologists.
format Online
Article
Text
id pubmed-5848406
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58484062018-03-21 An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar Bener, Abdulbari Alsulaiman, Reem Doodson, Lisa El Ayoubi, Hanadi R. J Family Med Prim Care Original Article INTRODUCTION: Breast cancer has been the most common cancer type that affects women worldwide and subsequent treatment is often associated with considerable psychological and quality of life (QoL). AIM: This study aimed to assess psychometric properties of the Arabic version of the European Organization for Research and Treatment of Cancer (EORTC) general QoL questionnaire (QLQ-C30) for breast cancer patients in Qatar. MATERIALS AND METHODS: This is a cross-sectional hospital-based study conducted on 678 breast cancer patients using Arabic version of the EORTC QLQ-C30 tool. RESULTS: The mean age of women was 47.7 ± 10.2 years and 33.4% of women had consanguineous parents. Six subscales out of the nine met the standards of reliability with coefficients ranging from 0.55 to 0.89. The mean score of all functioning scales was high >55. Advanced breast cancer stages of III–IV had higher symptomatic scores significantly than those in early stages for the physical function, cognitive, fatigue, insomnia, appetite loss, constipation, and financial difficulties. Correlation coefficients between each item ranged from –0.113 to 0.960, and item 21 (tense) and item 23 (irritable) had strongest negative correlations with their corresponding emotional functioning subscale, whereas items 29 (physical condition) and 30 (overall QoL) had the strongest positive correlation with Global Health/QoL subscale. Item 6 (limited work) showed a higher correlation with fatigue (r = 0.749). Likewise, item 19 (pain interfered with daily activities) of the pain subscale had higher correlations with physical functioning, role functioning, and fatigue subscales. CONCLUSION: Qatari Arabic version of the EORTC QLQ-C30 showed acceptable psychometric properties, which is a reliable and valid instrument, that can be used by oncologists. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5848406/ /pubmed/29564271 http://dx.doi.org/10.4103/jfmpc.jfmpc_17_17 Text en Copyright: © 2018 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bener, Abdulbari
Alsulaiman, Reem
Doodson, Lisa
El Ayoubi, Hanadi R.
An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar
title An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar
title_full An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar
title_fullStr An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar
title_full_unstemmed An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar
title_short An assessment of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 among breast cancer patients in Qatar
title_sort assessment of reliability and validity of the european organization for research and treatment of cancer quality of life questionnaire c30 among breast cancer patients in qatar
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848406/
https://www.ncbi.nlm.nih.gov/pubmed/29564271
http://dx.doi.org/10.4103/jfmpc.jfmpc_17_17
work_keys_str_mv AT benerabdulbari anassessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar
AT alsulaimanreem anassessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar
AT doodsonlisa anassessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar
AT elayoubihanadir anassessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar
AT benerabdulbari assessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar
AT alsulaimanreem assessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar
AT doodsonlisa assessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar
AT elayoubihanadir assessmentofreliabilityandvalidityoftheeuropeanorganizationforresearchandtreatmentofcancerqualityoflifequestionnairec30amongbreastcancerpatientsinqatar